Provided by Tiger Fintech (Singapore) Pte. Ltd.

ADMA Biologics

16.99
+0.02000.12%
Post-market: 17.000.0100+0.06%19:08 EDT
Volume:3.11M
Turnover:52.55M
Market Cap:4.05B
PE:20.10
High:17.02
Open:16.88
Low:16.61
Close:16.97
52wk High:25.67
52wk Low:13.50
Shares:238.63M
Float Shares:233.86M
Volume Ratio:0.82
T/O Rate:1.33%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.8451
EPS(LYR):0.8481
ROE:71.23%
ROA:20.81%
PB:10.18
PE(LYR):20.03

Loading ...

Company Profile

Company Name:
ADMA Biologics
Exchange:
NASDAQ
Establishment Date:
2004
Employees:
685
Office Location:
465 State Route 17,Ramsey,New Jersey,United States
Zip Code:
07446
Fax:
201 478 5553
Introduction:
ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primary humoral immunodeficiency (PI); ASCENIV, an IVIG product for the treatment of PI; and Nabi-HB for the treatment of acute exposure to blood containing Hepatitis B surface antigen and other listed exposures to Hepatitis B. The company also develops a pipeline of plasma-derived therapeutics, including products related to the methods of treatment and prevention of S. pneumonia infection for an immunoglobulin. In addition, it operates source plasma collection facilities. The company sells its products through independent distributors, drug wholesalers, specialty pharmacies, and other alternate site providers. ADMA Biologics, Inc. was incorporated in 2004 and is headquartered in Ramsey, New Jersey.

Directors

Name
Position
Adam S. Grossman
Co-Founder, Director, President and Chief Executive Officer
Jerrold B. Grossman
Director,Co-Founder and Vice Chairman
Steven A. Elms
Chairman and Director
Bryant E. Fong
Director
Dov A. Goldstein
Director
Eric I. Richman
Director
Lawrence P. Guiheen
Director

Shareholders

Name
Position
Adam S. Grossman
Co-Founder, Director, President and Chief Executive Officer
Brian Lenz
Vice President and Chief Financial Officer
James Mond
Executive Vice President, Chief Scientific Officer and Chief Medical Officer